Cell culture is 'next big pharmaceutical trend'
GBI Research is predicting strong growth in the global cell culture market thanks to increasing demand for biologics and stem cell therapies
Cell culture is fast becoming the next big trend in the pharmaceutical industry, according to a new report from GBI Research.
Projected figures suggest that the global cell culture market will grow at a compound annual growth rate (CAGR) of 9.3 per cent between 2011 and 2018, from $3.4 billion in 2011 to $6.3 billion in 2018.
The business intelligence firm observed that laboratories are in a "rush to meet demand for stem cell and biologics", the manufacturing of which requires cell culture methods.
These techniques involve the isolation of cells, which are then grown in an artificial, controlled environment.
GBI Research pointed out that biopharmaceuticals are less toxic and more effective than small molecule drugs and are "attracting the focus of many major companies".
"The development and manufacturing of these biological products is directly related to the growing demand for cell culture," the company claimed.
Referring to stem cell research, GBI Research argued that this growing field has "enormous potential" for cell culture, which ensures the production of highly purified stem cells and their progeny.
Stem cell therapies represent a "potential goldmine", as they treat the cause of a disease, whereas convention therapies merely manage its symptoms, the company added.
Related News
-
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News CPHI Podcast Series: Exploring neurological frontiers in Alzheimer's and beyond
The next episode of the CPHI Podcast Series delves into the science and background behind some recent developments in the field of Alzheimer's disease and neurological disorders. -
News Is patient centricity the future of pharmaceutical manufacturing?
In this interview with Sandra Sánchez y Oldenhage, President of PharmAdvice, she speaks to the importance of considering patients in the manufacturing stages of the pharmaceutical supply chain, and how it can redefine healthcare. -
News CPHI Podcast Series: How to leverage AI for Drug Discovery
Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare. -
News Pfizer forges ahead with blood cancer therapy after approval from FDA
Pfizer gains accelerated approval from the US FDA for their new bispecific antibody therapy for multiple myeloma, set to address an unmet need for patients. -
News Alzheimer's drug donanemab deemed effective in landmark clinical trial
Results from the TRAILBLAZER-ALZ 2 Randomised Clinical Trial into the use of donanemab to treat early symptoms of Alzheimer’s disease have been analysed.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance